These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16941531)

  • 1. Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy.
    Wood CG
    J Surg Oncol; 2006 Sep; 94(4):264-5. PubMed ID: 16941531
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
    Brouwers AH; Mulders PF; Oyen WJ
    J Clin Oncol; 2008 Aug; 26(22):3808-9; author reply 3811-2. PubMed ID: 18669472
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component.
    Skapa P; Hyrsl L; Zavada J; Soukup J; Zamecnik J
    J Clin Oncol; 2008 Aug; 26(22):3809-11; author reply 3811-2. PubMed ID: 18669473
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status and future directions of molecular markers in renal cell carcinoma.
    Rini BI
    Curr Opin Urol; 2006 Sep; 16(5):332-6. PubMed ID: 16905977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
    Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
    Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX/G250/MN: a molecule too good to be true?
    Oosterwijk E
    BJU Int; 2008 Mar; 101(5):527-8. PubMed ID: 18257853
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney cancer: Carbonic anhydrase IX in resected clear cell RCC.
    Pickering LM; Larkin J
    Nat Rev Urol; 2015 Jun; 12(6):309-10. PubMed ID: 26032554
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.
    Shuch B; Li Z; Belldegrun AS
    BJU Int; 2008 Jun; 101 Suppl 4():25-30. PubMed ID: 18430119
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
    Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
    Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
    PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX: historical and future perspectives.
    Oosterwijk E
    BJU Int; 2008 Jun; 101 Suppl 4():2-7. PubMed ID: 18430115
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous metastasis of renal cell carcinoma.
    Lee HJ; Lee A; Tan D; Du J; Wang Y; Tang PY; Sim ASP
    Lancet Oncol; 2020 May; 21(5):e292. PubMed ID: 32359504
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
    Lam JS; Leppert JT; Figlin RA; Belldegrun AS
    Urology; 2005 Nov; 66(5 Suppl):1-9. PubMed ID: 16194700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
    Lamers CH; Sleijfer S; Vulto AG; Kruit WH; Kliffen M; Debets R; Gratama JW; Stoter G; Oosterwijk E
    J Clin Oncol; 2006 May; 24(13):e20-2. PubMed ID: 16648493
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
    Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2005 Aug; 96(3):281-5. PubMed ID: 16042714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
    Zisman A; Pantuck AJ; Bui MH; Said JW; Caliliw RR; Rao N; Shintaku P; Berger F; Gambhir SS; Belldegrun AS
    Cancer Res; 2003 Aug; 63(16):4952-9. PubMed ID: 12941820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapy.
    Kim HS; Kim WS; Park SH; Jung CW; Choi HY; Lee HM; Jeon SS; Ha H; Hwang IG; Lee S; Lim HY
    Urol Oncol; 2010; 28(2):157-63. PubMed ID: 18976937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR.
    Kowalewska M; Radziszewski J; Kulik J; Barathova M; Nasierowska-Guttmajer A; Bidziński M; Pastorek J; Pastorekova S; Siedlecki JA
    Int J Cancer; 2005 Oct; 116(6):957-62. PubMed ID: 15856466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma.
    Jensen HK; Nordsmark M; Donskov F; Marcussen N; von der Maase H
    BJU Int; 2008 Jun; 101 Suppl 4():41-4. PubMed ID: 18430123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.